Illumina, DOJ Reach $9.8 Million False Claims Act Settlement

Illumina Inc. has agreed to pay $9.8 million to resolve allegations that it violated the False Claims Act by selling genomic sequencing systems with cybersecurity vulnerabilities to federal agencies, the US Justice Department said Thursday.

The settlement resolves claims that, between February 2016 and September 2023, Illumina knowingly failed to incorporate proper cybersecurity measures in its software design, development, installation, and monitoring for the genomic sequencing systems sold to government agencies. The company also allegedly failed to adequately address vulnerabilities, support personnel tasked with product security, and falsely represented adherence to cybersecurity standards.

While not admitting liability, Illumina agreed ...